
Current Paradigms in Cardiovascular Care of the Cancer Patient / SURVIVOR
Biennial, multidisciplinary, interprofessional educational symposium aimed at addressing the latest advances and clinical strategies in managing cardiovascular risks associated with cancer therapies.
Friday, October 3, 2025 | 7:30 AM – 3:30 PM | Waldorf Astoria Chicago
The Heart of Cardio-Oncology Care
-
KEYNOTE SPEAKER
Northwestern Memorial HealthCare
Dr. Clyde Yancy, Vice Dean at Northwestern, is a nationally recognized cardiologist with 500+ publications and deep expertise in heart failure. A leader in advancing equity and cardiovascular care, his work spans research, mentorship, and public health.
-
CHAIR & COURSE DIRECTOR
Rush University Medical Center
Dr. Tochukwu Okwuosa is a leader in cardio-oncology, known for building innovative programs that improve care for patients with cancer and heart disease. She’s also a dedicated educator shaping future providers through national and regional initiatives.
-
Supporting Faculty
Rush University Medical Center
Dr. Annabelle S. Volgman, founding director of the Rush Heart Center for Women, is a champion for women’s heart health. Her work blends research, clinical care, and advocacy to elevate awareness and treatment of cardiovascular disease in women.
This accredited one-day symposium will feature didactic lectures, panel discussions, and poster presentations, all led by distinguished experts.
-
Who
Physicians: Cardiologists, oncologists, internists, and hospitalists
Advanced Practice Providers: Nurse practitioners and physician assistants
Pharmacists and Nurses
Medical trainees and fellows
Professionals interested in improving cancer survivorship and reducing treatment-related cardiac complications
-
What
A full-day, single-track program of didactic lectures, expert panels, and poster presentations
Ample networking opportunities with clinicians, researchers, and industry leaders
Up to 5.25 hours of CME/CE credit for physicians, nurses, and pharmacists
Hosted in the elegant Waldorf Astoria Chicago, offering a professional and focused setting for learning and collaboration
-
Why
This biennial CME-accredited conference explores the evolving intersection of cancer therapies and cardiovascular care. Led by experts from Rush University Medical Center, it brings providers together for an immersive, cross-disciplinary experience. As treatments like chemo, radiation, and CAR-T evolve, so do their cardiac risks. This event equips clinicians to prevent, detect, and manage cancer therapy–related cardiac dysfunction (CTRCD) across the care continuum.

Where
Waldorf Astoria
11 E. Walton Street, Chicago IL
Friday, October 3, 2025
7:30 AM – 3:30 PM
Faculty & Expert Speakers
Driving the Future of Cardio-Oncology
Cardio-Oncology Topic Overview
-
Cardiotoxicity of chemotherapy, radiation, and targeted therapies
-
Immune checkpoint inhibitors and associated cardiovascular side effects
-
Cardiovascular implications of CAR-T cell therapy and stem cell transplants
-
Practical strategies for mitigating cardiovascular risks
-
Artificial Intelligence in Cardio-Oncology
-
Cardiovascular considerations in cancer survivorship
-
Novel treatments: SGLT2 inhibitors, GLP-1 agonists, NOACs, Others
-
Advanced cardiovascular imaging for early detection and management: Cardiac MRI, PET, CT, 3D Echo